XONELAR Trademark
Trademark Overview
On Thursday, October 16, 2003, a trademark application was filed for XONELAR with the United States Patent and Trademark Office. The USPTO has given the XONELAR trademark a serial number of 78314507. The federal status of this trademark filing is ABANDONED - EXPRESS as of Friday, August 27, 2004. This trademark is owned by Agouron Pharmaceuticals, Inc.. The XONELAR trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, ophthalmological preparations, preparations for the treatment of HIV and AIDS
General Information
| Serial Number | 78314507 |
| Word Mark | XONELAR |
| Filing Date | Thursday, October 16, 2003 |
| Status | 601 - ABANDONED - EXPRESS |
| Status Date | Friday, August 27, 2004 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, May 25, 2004 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, ophthalmological preparations, preparations for the treatment of HIV and AIDS |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 31, 2003 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Agouron Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | Agouron Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
Trademark Events
| Event Date | Event Description |
| Friday, August 27, 2004 | ABANDONMENT - EXPRESS MAILED |
| Monday, August 30, 2004 | PAPER RECEIVED |
| Tuesday, August 17, 2004 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, May 25, 2004 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 5, 2004 | NOTICE OF PUBLICATION |
| Wednesday, March 24, 2004 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 24, 2004 | ASSIGNED TO EXAMINER |
